Zhejiang Gongdong Medical Technology Co., Ltd.

SHSE:605369 Stock Report

Market Cap: CN¥4.8b

Zhejiang Gongdong Medical Technology Future Growth

Future criteria checks 5/6

Zhejiang Gongdong Medical Technology is forecast to grow earnings and revenue by 30.8% and 25.2% per annum respectively. EPS is expected to grow by 30.6% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

30.8%

Earnings growth rate

30.6%

EPS growth rate

Medical Equipment earnings growth26.6%
Revenue growth rate25.2%
Future return on equity16.8%
Analyst coverage

Low

Last updated11 Sep 2024

Recent future growth updates

No updates

Recent updates

There Are Reasons To Feel Uneasy About Zhejiang Gongdong Medical Technology's (SHSE:605369) Returns On Capital

Sep 23
There Are Reasons To Feel Uneasy About Zhejiang Gongdong Medical Technology's (SHSE:605369) Returns On Capital

Zhejiang Gongdong Medical Technology Co., Ltd.'s (SHSE:605369) P/E Still Appears To Be Reasonable

Jun 07
Zhejiang Gongdong Medical Technology Co., Ltd.'s (SHSE:605369) P/E Still Appears To Be Reasonable

Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Mar 28
Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump

Mar 06
Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump

Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return

Feb 27
Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return

Earnings and Revenue Growth Forecasts

SHSE:605369 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,0513744915372
12/31/20251,7003113644222
12/31/20241,3792461964102
9/30/20241,09816286217N/A
6/30/20241,07114388186N/A
3/31/20241,02112589188N/A
12/31/202397510964185N/A
9/30/20231,002106112189N/A
6/30/20231,128176136248N/A
3/31/20231,347260143268N/A
12/31/20221,469326111283N/A
9/30/20221,527367138382N/A
6/30/20221,4173443285N/A
3/31/20221,28032732350N/A
12/31/20211,19431197373N/A
9/30/20211,088319326269N/A
6/30/20211,068313208379N/A
3/31/2021989281177304N/A
12/31/2020830226134242N/A
9/30/2020744191-160220N/A
6/30/202063815558142N/A
3/31/202052911320113N/A
12/31/201955311420122N/A
12/31/20184838667102N/A
12/31/201743154N/A86N/A
12/31/201637161N/A86N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 605369's forecast earnings growth (30.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 605369's earnings (30.8% per year) are forecast to grow faster than the CN market (26.1% per year).

High Growth Earnings: 605369's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 605369's revenue (25.2% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 605369's revenue (25.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 605369's Return on Equity is forecast to be low in 3 years time (16.8%).


Discover growth companies